NMPA Accepts NDA for Innovent and HutchMed's Tyvyt and Elunate Combination
CompanyDrug

NMPA Accepts NDA for Innovent and HutchMed’s Tyvyt and Elunate Combination

SciBrunch Therapeutics Secures RMB 200 Million in Angel Financing Round
CompanyDeals

SciBrunch Therapeutics Secures RMB 200 Million in Angel Financing Round

JW Therapeutics' Carteyva Approved by Macau Health Bureau
CompanyDrug

JW Therapeutics’ Carteyva Approved by Macau Health Bureau

Sichuan Kelun-Biotech Raises $250M in Hong Kong's Largest Follow-On Offering
CompanyDeals

Sichuan Kelun-Biotech Raises $250M in Hong Kong’s Largest Follow-On Offering

Easton Pharma's Oxazepam Receives NMPA Approval and Partners with Nhwa
CompanyDeals

Easton Pharma’s Oxazepam Receives NMPA Approval and Partners with Nhwa

Sanofi's Rilzabrutinib Granted Orphan Drug Designation for Sickle Cell Disease
CompanyDrug

Sanofi’s Rilzabrutinib Granted Orphan Drug Designation for Sickle Cell Disease

Ascletis Pharma's Denifanstat Meets Phase III Endpoints in Severe Acne Trial
CompanyDrug

Ascletis Pharma’s Denifanstat Meets Phase III Endpoints in Severe Acne Trial

Eli Lilly Partners with Camurus on Long-Acting Cardiovascular and Metabolic Health Products
CompanyDeals

Eli Lilly Partners with Camurus on Long-Acting Cardiovascular and Metabolic Health Products

CirCode Biomed's Circular RNA Drug HM2002 Approved for US Clinical Trials
CompanyDrug

CirCode Biomed’s Circular RNA Drug HM2002 Approved for US Clinical Trials

Bio-heart Launches Iberis Renal Ablation System at OCC 2025
CompanyMedical Device

Bio-heart Launches Iberis Renal Ablation System at OCC 2025

BioAge Labs Partners with JiKang for APJ Agonist Nanobody License
CompanyDeals

BioAge Labs Partners with JiKang for APJ Agonist Nanobody License

Bayer's Nubeqa Gets FDA Approval for mHSPC Treatment
CompanyDrug

Bayer’s Nubeqa Gets FDA Approval for mHSPC Treatment